Company Filing History:
Years Active: 2002
Title: Wayne G. Godfry: Innovator in Hematopoietic Stem Cell Research
Introduction
Wayne G. Godfry is a notable inventor based in Atherton, California. He has made significant contributions to the field of hematopoietic stem cell research. His work focuses on the identification and characterization of specific cell antigens that play a crucial role in stem cell biology.
Latest Patents
Wayne G. Godfry holds a patent for a human hematopoietic stem and progenitor cell antigen. This patent describes a hematopoietic progenitor cell antigen and reagents, notably antibodies, that specifically bind to the antigen. The expression of this antigen is highly tissue-specific and is only detected on a subset of hematopoietic progenitor cells derived from human bone marrow, fetal bone marrow, liver, cord blood, and adult peripheral blood. The subset of cells recognized by AC133 is CD34 and contains substantially all of the CFU-GM activity present in the CD34 population. This highly specific distribution of AC133 makes it exceptionally useful as a reagent for isolating and characterizing human hematopoietic progenitor and stem cells.
Career Highlights
Wayne G. Godfry is associated with Amcell Corporation, where he has contributed to advancements in stem cell research. His work has implications for both therapeutic applications and research methodologies in the field of hematology.
Collaborations
Wayne has collaborated with notable coworkers, including Amy H. Yin and Sheri Miraglia, who have also contributed to the research and development of hematopoietic stem cell technologies.
Conclusion
Wayne G. Godfry's innovative work in hematopoietic stem cell research has led to significant advancements in the understanding and application of stem cell biology. His contributions continue to impact the field positively.